Jpmorgan Chase & CO Tela Bio, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Tela Bio, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 339 shares of TELA stock, worth $989. This represents 0.0% of its overall portfolio holdings.
Number of Shares
339
Previous 905
62.54%
Holding current value
$989
Previous $4,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding TELA
# of Institutions
55Shares Held
18.3MCall Options Held
759KPut Options Held
100-
Essex Woodlands Management, Inc. The Woodlands, TX4.11MShares$12 Million2.98% of portfolio
-
Aigh Capital Management LLC Baltimore, MD2.47MShares$7.21 Million2.52% of portfolio
-
Orbimed Advisors LLC San Diego, CA2.16MShares$6.31 Million0.13% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.92MShares$5.59 Million0.29% of portfolio
-
Silverarc Capital Management, LLC1.12MShares$3.28 Million0.71% of portfolio
About TELA Bio, Inc.
- Ticker TELA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 19,157,600
- Market Cap $55.9M
- Description
- TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...